BEIJING — China’s National Health Commission (NHC) has updated its rules on the diagnosis of COVID-19 cases, stating that diagnosis based on the presence of antibodies only applies to those who have not yet been vaccinated.
Étiqueté : anticorps
[Chine] Coronavirus: low level of antibodies present in China’s population and vaccine is needed ‘urgently’, says country’s leading expert Zhong Nanshan
– Study conducted in Wuhan, the initial centre of the outbreak, and Guangzhou finds tiny proportion of population had developed antibodies
– Strict isolation and community measures should be continued until a vaccine is available, says a paper led by Zhong
– With a coronavirus vaccine or cure seemingly nowhere near, researchers are now looking closely at antibody therapy
– At least five antibody treatments are now in the works, with most of them in Asian labs, including Singapore, Japan, South Korea and mainland China
Only 0.1 percent of people in Tokyo tested positive for antibodies against the coronavirus, a survey conducted by the health ministry found Tuesday, indicating the spread of the virus in Japan’s capital remains limited, even though the number of cases may be higher than those already found.
Début avril, l’équipe composée des chercheurs de l’Université et de l’hôpital Chang Gung, de l’Academia Sinica, du centre médical du ministère de la Défense et de l’Université Oxford avaient identifié 25 anticorps monoclonaux sur les patients atteints du Covid-19. Aujourd’hui, l’hôpital Chang Gung annonce avoir trouvé un anticorps monoclonal capable d’empêcher le virus du SARS-CoV-2 de pénétrer dans le corps humain avec une capacité de l’inhiber allant de 90% à 98%.